Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 48 | 03/08/20 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06/07/21 |
Kristen Allgor
HRO | Human Resources Officer | - | 16/11/20 |
John Harlow
PRN | Corporate Officer/Principal | - | 30/03/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20/04/20 |
Director/Board Member | - | 20/04/20 | |
Director/Board Member | - | 20/04/20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03/08/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 13 750 691 | 13 578 334 ( 98,75 %) | 0 | 98,75 % |
Coordinate società
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.com![Indirizzo Melinta Therapeutics Inc](https://cdn.zonebourse.com/static/address/38588350.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,12% | 126 Mrd | |
+25,25% | 119 Mrd | |
+25,56% | 27,95 Mrd | |
-19,51% | 20,5 Mrd | |
-14,36% | 17,12 Mrd | |
-15,63% | 16,1 Mrd | |
-46,67% | 14,97 Mrd | |
+11,89% | 14,84 Mrd | |
+57,74% | 14,38 Mrd |